Announcements Trials
Browse Landscape

Status

Completed 4Withdrawn 1Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 127Observational 4

Sponsor

Cancer Type

Genitourinary 3Breast 1

Conditions

Prostatic Neoplasms 3Sarcopenia 1Patient Compliance 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 59Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Bevacizumab 40Reverse Transcriptase Polymerase Chain Reaction 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Hepatectomy 25Therapeutics 24Neoadjuvant Therapy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Observational × Goserelin × Clear all
NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Pfizer

Completed
1,083 enrolled 29 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Fudan University

Completed
562 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT02366494 2024-11-25

Micro RNAs to Predict Response to Androgen Deprivation Therapy

Medical College of Wisconsin

Completed
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT03867357 2024-09-04

Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

Seattle Institute for Biomedical and Clinical Research

Completed
60 enrolled
Genitourinary

Prostatic Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡